نتائج البحث

LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.

• Authors : Traverse JH; Henry TD ...

Subjects: Angioplasty, Balloon, Coronary* ; Bone Marrow Transplantation*/Bone Marrow Transplantation*/Bone Marrow Transplantation*/adverse effects; Heart Failure/Heart Failure/Heart Failure/*prevention & control

• Source: Texas Heart Institute journal [Tex Heart Inst J] 2010; Vol. 37 (4), pp. 412-20.Publisher: published in the Cardiovascular Surgical Research Laboratories, Texas Heart Institute Country of Publication: United States NLM ID: 8214622 Publication

تفاصيل العنوان

LateTIME.

• Authors : Traverse, Jay H.^1,2,3; Henry, Timothy D.^2,3; Vaughan, Douglas E.⁴

• Source: Texas Heart Institute Journal. 2010, Vol. 37 Issue 4, p412-420. 9p. 4 Charts.

تفاصيل العنوان